Pharmacy

The FINANCIAL -- Teva Pharmaceutical Industries Ltd., on June 12 announced the launch of generic Zetia®1 (ezetimibe) tablets, 10 mg,...

The FINANCIAL -- Gilead Sciences, Inc. on June 12 announced that it has submitted a New Drug Application (NDA) to...

The FINANCIAL -- AstraZeneca presented new data at the American Diabetes Association’s (ADA) 77th Scientific Sessions underpinning the safety profile...

The FINANCIAL -- Boehringer Ingelheim and Eli Lilly and Company on June 12 announced to conduct a new, large clinical...

The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. on June 11 announced positive results from two Phase 3b/4 ODYSSEY-DM trials...

The FINANCIAL -- For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who...

The FINANCIAL -- New advice on which antibiotics to use for common infections and which to preserve for the most...

The FINANCIAL -- Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. on June 7 announced that data from the...

The FINANCIAL -- AstraZeneca on June 7 announced that it has entered an agreement with Grünenthal for the global rights...

The FINANCIAL -- Novartis announced on June 6 that the European Commission (EC) has approved the inclusion of Treatment-free Remission...

The FINANCIAL -- Amgen on June 4 announced new data from the XGEVA (denosumab) Phase 3 '482 study, the largest...

The FINANCIAL -- Novartis announced on June 2 updated findings from the Phase III MONALEESA-2 study that reinforce the efficacy...

The FINANCIAL -- AstraZeneca announced that, effective 1 June 2017, the Board has appointed Professor Nazneen Rahman as a Non-Executive...

  The FINANCIAL -- Pfizer Inc. on May 31 announced that a supplemental New Drug Application (sNDA) for SUTENT® (sunitinib)...

The FINANCIAL -- Eli Lilly and Company announced on June 1 that Derica Rice, executive vice president global services and...